financetom
Business
financetom
/
Business
/
RH Faces Earnings Headwinds From Tariffs, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RH Faces Earnings Headwinds From Tariffs, Oppenheimer Says
Sep 15, 2025 6:23 PM

03:23 PM EDT, 09/15/2025 (MT Newswires) -- RH's (RH) profitability will likely come under pressure over the coming quarters amid challenges related to tariffs, Oppenheimer said in a client note e-mailed Monday.

The brokerage lowered its fiscal 2025 and 2026 earnings-per-share estimates for the home furnishing retailer after scrutinizing trends and having discussions with its senior management.

Last week, RH lowered its full-year revenue growth outlook amid persistent tariff-related uncertainties, while its fiscal second-quarter results came in below market expectations.

"Overall, while we are encouraged somewhat by clearer indications of stabilizing, if not improving demand trends at RH, we are turning increasingly concerned that now significantly elevated tariffs could interrupt top- and bottom-line momentum at the chain over coming quarters," Oppenheimer analysts, including Brian Nagel, said in the note.

The brokerage is now projecting EPS of $8.48 for fiscal 2025 and $12 for fiscal 2026, compared with its previous estimates of $10.39 and $13.15, respectively. Consensus forecasts indicate $9.03 and $14.31, respectively.

Oppenheimer said the 2025 forecast is based on a reduced operating margin estimate.

RH is "aggressively responding" to the recently imposed tariffs of 50% on India, which impact 7% of its business, "almost entirely hand knotted rugs," Chief Executive Gary Friedman said in a shareholder letter last week.

"Debt service coverage remains a risk for RH, particularly against a more precarious sector backdrop," Nagel wrote. "We advise clients seeking opportunity within home furnishings to focus on shares of outperform-rated Wayfair ( W ) ."

Oppenheimer has a perform rating on RH shares.

Price: 225.00, Change: +7.38, Percent Change: +3.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NextEra reports lower second-quarter profit
NextEra reports lower second-quarter profit
Jul 24, 2024
July 24 (Reuters) - NextEra Energy's reported lower second-quarter net income on Wednesday, hurt by weakness in its utilities segment. The world's largest renewables company reported a net income of $1.62 billion, or 79 cents per share, compared with $2.8 billion, or $1.38 per share in the same quarter last year. (Reporting by Seher Dareen in Bengaluru) ...
Facebook removes 63,000 accounts in Nigeria over 'sextortion' scams
Facebook removes 63,000 accounts in Nigeria over 'sextortion' scams
Jul 24, 2024
LAGOS, July 24 (Reuters) - Meta Platforms ( META ) said on Wednesday it had removed about 63,000 Facebook accounts in Nigeria that attempted to engage in financial sexual extortion scams mostly aimed at adult men in the United States. Nigerian online fraudsters, known as Yahoo boys, are notorious for scams that range from passing themselves off as people in...
IDB and Brazil's public banks to launch Amazon ETF, say sources
IDB and Brazil's public banks to launch Amazon ETF, say sources
Jul 24, 2024
RIO DE JANEIRO, July 24 (Reuters) - The Inter-American Development Bank (IDB) and Brazil's public banks will announce on Thursday the development of an exchange-traded fund (ETF) focused on sustainable investments in the Amazon rainforest, said two people with direct knowledge. State development bank BNDES, Banco do Brasil and Caixa Economica Federal are part of the initiative, said the sources,...
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
Jul 24, 2024
07:40 AM EDT, 07/24/2024 (MT Newswires) -- Cannabis company Tilray Brands ( TLRY ) announced Wednesday that subsidiary Tilray Medical has received official approval for a new medical cannabis extract in Portugal. This follows the approval of Tilray Medical whole flower THC 18, and for the first cannabis extract in Portugal earlier this year. This is a significant step towards...
Copyright 2023-2026 - www.financetom.com All Rights Reserved